Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
US Department of Justice
McKinsey
Queensland Health
Healthtrust

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,987,242

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,987,242
Title:Morpholinone compounds as factor IXA inhibitors
Abstract: The present invention provides a compound of Formula (I) ##STR00001## as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
Inventor(s): Chackalamannil; Samuel (Califon, NJ), Chan; Tin-Yau (Edison, NJ), Chelliah; Mariappan V. (Edison, NJ), Clasby; Martin C. (Plainsboro, NJ), Dwyer; Michael (Scotch Plains, NJ), Greenlee; William J. (Teaneck, NJ), Hirabayashi; Tomokazu (Shinjuku-ku, JP), Neelamkavil; Santhosh (Scotch Plains, NJ), Nishida; Hidemitsu (Shinjuku-ku, JP), Saitoh; Fumihiko (Shinjuku-ku, JP), Shah; Unmesh (Green Brook, NJ), Xia; Yan (Edison, NJ)
Assignee: Merck Sharp & Dohme Corp. (Rahway, NJ) Mochida Pharmaceuticals Co., Ltd. (Tokyo, JP)
Application Number:12/791,464
Patent Claims:see list of patent claims

Details for Patent 8,987,242

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech TNKASE tenecteplase VIAL 103909 001 2000-06-02 ➤ Sign Up Merck Sharp & Dohme Corp. (Rahway, NJ) Mochida Pharmaceuticals Co., Ltd. (Tokyo, JP) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Deloitte
Accenture
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.